12:00 AM
Oct 08, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

CSL preclinical data

In prediabetic mice, 2H10 significantly prevented the development of hyperglycemia compared to a control antibody (p<0.01). Additionally, 2H10 improved glucose tolerance and plasma HDL-C levels and prevented elevation of circulating triglyceride levels, LDL-C, non-esterified fatty...

Read the full 153 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >